Tools Automate. Platforms Compound.
Why Architecture — and Anatomy — Beat a Pile of Point Solutions in Pharma AI Every pharma R&D organization now owns more AI tools than it did three years ago — and, by most internal accounts, less clarity about what any of them are learning together. That paradox is the subject of a two-part series […]
10 mins read
The $2.6 Billion Lesson: What Pharma’s Failed Programs Are Trying to Tell Us
Every terminated drug program leaves behind a fingerprint of why it failed. AI can now read those fingerprints — and turn them into the blueprint for the next success Pharmaceutical R&D generates failure at an extraordinary rate — and buries it. >90% of discovery programs never reach an IND. ~70% of Phase II trials fail […]
6 mins read